CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Seraph 100Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1108 Hydroxychloroquine Sulfate 200 MG [Plaquenil] Wiki 0.58

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Registry for the Evaluation of Safety and Effectiveness of the Seraph 100 Microbind Affinity Blood Filter in the Therapy of COVID-19 Patients (COSA)

The purpose of this registry study is to investigate the effectiveness and safety of the Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) in the treatment of COVID-19 patients.

NCT04361500 COVID-19 Device: Seraph 100

Primary Outcomes

Description: Overall Survival after Seraph 100 therapy session

Measure: Survival

Time: 30 days

Secondary Outcomes

Description: Time spend in the ICU after Seraph 100 therapy session

Measure: Length of ICU stay

Time: 30 days

Description: Time spend in the hospital after Seraph 100 therapy session

Measure: Length of Hospital stay

Time: 30 days

Description: Time spend on ventilator after Seraph 100 therapy session

Measure: Length of ventilator therapy

Time: 30 days

Description: Report of any Seraph 100 therapy related adverse events

Measure: Adverse events

Time: 30 days


No related HPO nodes (Using clinical trials)